Ischemic heart disease decisions — 2025

The Board denied service connection for a heart disability, finding no current diagnosis and that the Veteran's reported symptoms were not supported by medical evidence. The issues of service connection for a low back disability and entitlement to TDIU are remanded.

The Board remands the claim for a new medical opinion to address whether the Appellant's heart condition had onset during his period of ACDUTRA service.

The Board denied service connection for hypertension, a heart disorder, and diabetes mellitus as the evidence did not support a positive nexus between these conditions and the Veteran's military service.

The Board denied service connection for various disabilities, including an acquired psychiatric disability, headaches, a back disability, heart disability, and residuals of a stroke, as the evidence did not support a finding that these conditions were related to the Veteran's active service or caused by his service-connected left ear disabilities.

The appeal was denied for service connection of a cervical spine disorder, and several claims were remanded for further development.

The Board granted service connection for coronary artery disease, which is presumed related to in-service exposure to herbicide agents.

The Board granted service connection for a heart disability, to include atherosclerotic cardiovascular disease and coronary artery disease as secondary to the Veteran's service-connected disabilities. The claim for cervical degenerative arthritis was denied.

The Board denied service connection for bilateral hearing loss and a heart disability, granted service connection for bilateral tinnitus and right knee osteochondritis dissecans, anterior cruciate ligament (ACL) tear s/p ACL reconstruction, and denied an initial rating in excess of 50 percent for posttraumatic stress disorder with generalized anxiety disorder.

The Board denied a rating greater than 70 percent for PTSD, granted an earlier effective date of August 14, 2024, for the grant of a 70 percent rating for PTSD, and denied other claims including entitlement to an effective date prior to April 3, 2025, for the grant of a 100 percent rating evaluation for CAD.

The Board remands the case to obtain a new medical opinion regarding the Veteran's ischemic heart disease, as the previous opinions were found inadequate.

The Board denied service connection for hepatitis C and remanded the claim for a heart disability due to insufficient evidence.

The Board granted service connection for headache attributed to RCVS and persistent thunderclap headache, restored a disability rating of 60 percent for asthma with COPD, denied an initial rating greater than 60 percent for asthma with COPD, denied an initial rating greater than 10 percent for RCVS and aphasia, granted separate ratings for muscle weakness in the upper and lower extremities due to RCVS, denied a higher rating for myocardial infarction with arteriosclerotic heart disease, granted TDIU from August 23, 2023, and granted an effective date of August 23, 2023, for DEA benefits.

The Board denied service connection for pneumonia and remanded the claims for iodine allergy, pilonidal cyst, sulfa allergy, heart disability, acquired psychiatric disorder, and lower and upper extremity disabilities.

The Board denied service connection for a sleep disability and a heart disability, as well as a total disability rating based on individual unemployability prior to July 28, 2022.

The Board granted service connection for a heart disability, to include coronary artery disease (CAD), as secondary to the Veteran's anxiety and assigned a 70 percent rating from April 29, 2025. The Board also granted an initial 30 percent rating prior to that date.

The Board granted service connection for obstructive sleep apnea, diabetes mellitus, type II, left eye diabetic retinopathy, left foot diabetic peripheral neuropathy, right foot diabetic peripheral neuropathy, and coronary artery disease, as well as the Veteran's cause of death.

The Board denied service connection for a heart disability as the evidence did not support that it began during active service or was related to an in-service injury.

The Veteran is granted special monthly compensation (SMC) at the R(1) rate due to his need for regular aid and attendance.

The Board granted service connection for a heart disorder, specifically atrial fibrillation, due to exposure to herbicide agents during active duty service in the Republic of Vietnam.

The Board granted service connection for arteriosclerotic heart disease (CAD) with bypass graft as secondary to type II diabetes mellitus, and granted a 20 percent disability rating from July 15, 2021 through February 15, 2023 for certain diabetic neuropathies, while denying earlier effective dates and increased ratings for other conditions.